Applicant, as named in the Orange Book

Averitas

Next listed expiry: Qutenza on 26 Mar 2030. 2 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Qutenza capsaicin	capsaicin	022395	26 Mar 2030	patent
Movantik · 2 strengths naloxegol oxalate	naloxegol oxalate	204760	2 Apr 2032	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.